STRATA Skin Sciences announced the launch of the new XTRAC website. The new website educates patients on XTRAC excimer laser therapy for the treatment of psoriasis, vitiligo, and atopic dermatitis. "We are proud to announce the launch of our new XTRAC website," stated Bob Moccia, Chief Executive Officer of STRATA Skin Sciences. "Our goal in designing this new resource is to increase product awareness, make it easy for patients to seek out treatment at their convenience, and ultimately allow more patients with these conditions to benefit from XTRAC therapy."
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SSKN:
- Strata Skin Sciences regains compliance with Nasdaq
- STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Inaugural Winter Clinical Conference
- Strata Skin Sciences sees 2022 revenue $35M-$36M, consensus $34.35M
- STRATA Skin Sciences Announces Poster Accepted at ODAC Dermatology, Aesthetic & Surgical Conference
- Strata Skin Sciences announces poster presentation on photopneumatic therapy